Home > > > > > Report Detail

Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 07-Sep-2022
No. of pages: 106
Inquire Before Buying

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Tuberculosis (TB) Diagnostics market is projected to reach US$ 3592.2 million by 2028 from an estimated US$ 2758.4 million in 2022, at a CAGR of 4.5% during 2023 and 2028.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis (TB) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Tuberculosis (TB) Diagnostics.

The Tuberculosis (TB) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tuberculosis (TB) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Danaher

- Roche

- Thermo Fisher Scientific

- BD

- Abbott

- Hologic

- Qiagen

- BioMerieux

- Hain Lifescience

- Oxford Immunotec

Product Type Insights

Global markets are presented by Tuberculosis (TB) Diagnostics type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Tuberculosis (TB) Diagnostics are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Tuberculosis (TB) Diagnostics Segment by Type

- Culture-Based Diagnostics

- Sputum Smear Microscopy

- Rapid Molecular Diagnostics

- Others

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Tuberculosis (TB) Diagnostics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Tuberculosis (TB) Diagnostics market.

Tuberculosis (TB) Diagnostics Segment by Application

- Diagnostic Laboratories

- Hospitals

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Tuberculosis (TB) Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Tuberculosis (TB) Diagnostics industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Diagnostics.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Tuberculosis (TB) Diagnostics Product Introduction
1.2 Market by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tuberculosis (TB) Diagnostics Market Size Estimates and Forecasts
2.2 Tuberculosis (TB) Diagnostics Market Size by Region: 2022 Versus 2028
2.2.1 Global Tuberculosis (TB) Diagnostics Revenue by Region: 2017-2022
2.2.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2023-2028)
2.2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2017-2028)
3 Global Tuberculosis (TB) Diagnostics by Company
3.1 Global Tuberculosis (TB) Diagnostics Revenue by Company (2017-2022)
3.2 Global Tuberculosis (TB) Diagnostics Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Tuberculosis (TB) Diagnostics Companies around the World: Ranking by Revenue
3.3.2 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Tuberculosis (TB) Diagnostics Companies Headquarters & Product Type
3.4.1 Tuberculosis (TB) Diagnostics Companies Headquarters
3.4.2 Global Tuberculosis (TB) Diagnostics Companies Product & Service
3.4.3 Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
3.5 Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Danaher
4.1.1 Danaher Corporation Information
4.1.2 Danaher Description, Business Overview
4.1.3 Danaher Tuberculosis (TB) Diagnostics Products Offered
4.1.4 Danaher Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.1.5 Danaher Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.1.6 Danaher Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.1.7 Danaher Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.1.8 Danaher Recent Developments
4.2 Roche
4.2.1 Roche Corporation Information
4.2.2 Roche Description, Business Overview
4.2.3 Roche Tuberculosis (TB) Diagnostics Products Offered
4.2.4 Roche Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.2.5 Roche Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.2.6 Roche Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.2.7 Roche Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.2.8 Roche Recent Developments
4.3 Thermo Fisher Scientific
4.3.1 Thermo Fisher Scientific Corporation Information
4.3.2 Thermo Fisher Scientific Description, Business Overview
4.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Products Offered
4.3.4 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.3.5 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.3.6 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.3.7 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.3.8 Thermo Fisher Scientific Recent Developments
4.4 BD
4.4.1 BD Corporation Information
4.4.2 BD Description, Business Overview
4.4.3 BD Tuberculosis (TB) Diagnostics Products Offered
4.4.4 BD Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.4.5 BD Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.4.6 BD Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.4.7 BD Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.4.8 BD Recent Developments
4.5 Abbott
4.5.1 Abbott Corporation Information
4.5.2 Abbott Description, Business Overview
4.5.3 Abbott Tuberculosis (TB) Diagnostics Products Offered
4.5.4 Abbott Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.5.5 Abbott Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.5.6 Abbott Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.5.7 Abbott Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.5.8 Abbott Recent Developments
4.6 Hologic
4.6.1 Hologic Corporation Information
4.6.2 Hologic Description, Business Overview
4.6.3 Hologic Tuberculosis (TB) Diagnostics Products Offered
4.6.4 Hologic Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.6.5 Hologic Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.6.6 Hologic Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.6.7 Hologic Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.6.8 Hologic Recent Development
4.7 Qiagen
4.7.1 Qiagen Corporation Information
4.7.2 Qiagen Description, Business Overview
4.7.3 Qiagen Tuberculosis (TB) Diagnostics Products Offered
4.7.4 Qiagen Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.7.5 Qiagen Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.7.6 Qiagen Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.7.7 Qiagen Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.7.8 Qiagen Recent Development
4.8 BioMerieux
4.8.1 BioMerieux Corporation Information
4.8.2 BioMerieux Description, Business Overview
4.8.3 BioMerieux Tuberculosis (TB) Diagnostics Products Offered
4.8.4 BioMerieux Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.8.5 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.8.6 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.8.7 BioMerieux Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.8.8 BioMerieux Recent Development
4.9 Hain Lifescience
4.9.1 Hain Lifescience Corporation Information
4.9.2 Hain Lifescience Description, Business Overview
4.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Products Offered
4.9.4 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.9.5 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.9.6 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.9.7 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.9.8 Hain Lifescience Recent Development
4.10 Oxford Immunotec
4.10.1 Oxford Immunotec Corporation Information
4.10.2 Oxford Immunotec Description, Business Overview
4.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Products Offered
4.10.4 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue and Gross Margin (2017-2022)
4.10.5 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Product in 2021
4.10.6 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Application in 2021
4.10.7 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue by Geographic Area in 2021
4.10.8 Oxford Immunotec Recent Development
5 Breakdown Data by Type
5.1 Global Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
5.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Type (2023-2028)
5.3 Tuberculosis (TB) Diagnostics Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
6.2 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2023-2028)
6.3 Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2017-2028
7.2 North America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2017-2028)
7.3 North America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
7.4 North America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
9 Europe
9.1 Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth 2017-2028
9.2 Europe Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2017-2028)
9.3 Europe Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
9.4 Europe Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth 2017-2028
10.2 Latin America Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2017-2028)
10.3 Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
10.4 Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Tuberculosis (TB) Diagnostics Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022)
11.4 Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Tuberculosis (TB) Diagnostics Supply Chain Analysis
12.2 Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
12.3 Tuberculosis (TB) Diagnostics Clients Analysis
12.4 Tuberculosis (TB) Diagnostics Sales Channel and Sales Model Analysis
12.4.1 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Tuberculosis (TB) Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Tuberculosis (TB) Diagnostics Distributors
13 Market Dynamics
13.1 Tuberculosis (TB) Diagnostics Industry Trends
13.2 Tuberculosis (TB) Diagnostics Market Drivers
13.3 Tuberculosis (TB) Diagnostics Market Challenges
13.4 Tuberculosis (TB) Diagnostics Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Culture-Based Diagnostics
Table 3. Major Companies of Sputum Smear Microscopy
Table 4. Major Companies of Rapid Molecular Diagnostics
Table 5. Major Companies of Others
Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2022 VS 2028
Table 8. Global Tuberculosis (TB) Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Tuberculosis (TB) Diagnostics Revenue by Company (2017-2022) & (US$ Million)
Table 11. Tuberculosis (TB) Diagnostics Revenue Share by Company (2017-2022)
Table 12. Ranking of Global Top Tuberculosis (TB) Diagnostics Players by Revenue (US$ Million) in 2021
Table 13. Global Tuberculosis (TB) Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 14. Global Tuberculosis (TB) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2021)
Table 15. Global Tuberculosis (TB) Diagnostics Companies Headquarters
Table 16. Global Tuberculosis (TB) Diagnostics Companies Product & Service
Table 17. Date of International Companies Enter into Tuberculosis (TB) Diagnostics Market
Table 18. Global Tuberculosis (TB) Diagnostics Mergers & Acquisitions, Expansion Plans
Table 19. Danaher Corporation Information
Table 20. Danaher Description and Business Overview
Table 21. Danaher Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 22. Danaher Tuberculosis (TB) Diagnostics Product
Table 23. Danaher Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 24. Danaher Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 25. Danaher Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 26. Danaher Recent Development
Table 27. Roche Corporation Information
Table 28. Roche Description and Business Overview
Table 29. Roche Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 30. Roche Tuberculosis (TB) Diagnostics Product
Table 31. Roche Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 32. Roche Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 33. Roche Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 34. Roche Recent Development
Table 35. Thermo Fisher Scientific Corporation Information
Table 36. Thermo Fisher Scientific Description and Business Overview
Table 37. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 38. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 39. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 40. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 41. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 42. Thermo Fisher Scientific Recent Development
Table 43. BD Corporation Information
Table 44. BD Description and Business Overview
Table 45. BD Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 46. BD Tuberculosis (TB) Diagnostics Product
Table 47. BD Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 48. BD Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 49. BD Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 50. BD Recent Development
Table 51. Abbott Corporation Information
Table 52. Abbott Description and Business Overview
Table 53. Abbott Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 54. Abbott Tuberculosis (TB) Diagnostics Product
Table 55. Abbott Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 56. Abbott Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 57. Abbott Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 58. Abbott Recent Development
Table 59. Hologic Corporation Information
Table 60. Hologic Description and Business Overview
Table 61. Hologic Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 62. Hologic Tuberculosis (TB) Diagnostics Product
Table 63. Hologic Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 64. Hologic Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 65. Hologic Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 66. Qiagen Corporation Information
Table 67. Qiagen Description and Business Overview
Table 68. Qiagen Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 69. Qiagen Tuberculosis (TB) Diagnostics Product
Table 70. Qiagen Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 71. Qiagen Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 72. Qiagen Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 73. BioMerieux Corporation Information
Table 74. BioMerieux Description and Business Overview
Table 75. BioMerieux Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 76. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 77. BioMerieux Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 78. BioMerieux Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 79. BioMerieux Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 80. Hain Lifescience Corporation Information
Table 81. Hain Lifescience Description and Business Overview
Table 82. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 83. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 84. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 85. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 86. Hain Lifescience Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 87. Oxford Immunotec Corporation Information
Table 88. Oxford Immunotec Description and Business Overview
Table 89. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue (US$ Million) and Gross Margin (2017-2022)
Table 90. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 91. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Product in 2021
Table 92. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Application in 2021
Table 93. Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue Proportion of Tuberculosis (TB) Diagnostics by Geographic Area in 2021
Table 94. Global Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 95. Global Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 96. Global Tuberculosis (TB) Diagnostics Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 97. North America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 98. North America Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 99. North America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 100. North America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 101. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2017-2028) & (US$ Million)
Table 102. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 103. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 104. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 105. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 106. Europe Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 107. Europe Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 108. Europe Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 110. Latin America Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 111. Latin America Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 112. Latin America Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 113. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 114. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 116. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 117. Tuberculosis (TB) Diagnostics Key Raw Materials, Industry Status and Trend
Table 118. Tuberculosis (TB) Diagnostics Key Raw Materials and Upstream Suppliers
Table 119. Tuberculosis (TB) Diagnostics Clients Status and Trend
Table 120. Tuberculosis (TB) Diagnostics Typical Clients
Table 121. Tuberculosis (TB) Diagnostics Distributors
Table 122. Tuberculosis (TB) Diagnostics Market Trends
Table 123. Tuberculosis (TB) Diagnostics Market Drivers
Table 124. Tuberculosis (TB) Diagnostics Market Challenges
Table 125. Tuberculosis (TB) Diagnostics Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis (TB) Diagnostics Product Picture
Figure 2. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type in 2021 & 2028
Figure 3. Culture-Based Diagnostics Product Picture
Figure 4. Sputum Smear Microscopy Product Picture
Figure 5. Rapid Molecular Diagnostics Product Picture
Figure 6. Others Product Picture
Figure 7. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application in 2021 & 2028
Figure 8. Diagnostic Laboratories
Figure 9. Hospitals
Figure 10. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 11. Global Tuberculosis (TB) Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Tuberculosis (TB) Diagnostics Market Size 2017-2028 (US$ Million)
Figure 13. Global Tuberculosis (TB) Diagnostics Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 15. Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Type (2017-2028)
Figure 17. Global Tuberculosis (TB) Diagnostics Revenue Market Share Forecast by Application (2017-2028)
Figure 18. North America Tuberculosis (TB) Diagnostics Revenue 2017-2028 (US$ Million)
Figure 19. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Figure 20. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Figure 21. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue 2017-2028 (US$ Million)
Figure 22. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 23. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Figure 24. Asia-Pacific Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Figure 25. Europe Tuberculosis (TB) Diagnostics Revenue Growth Rate 2017-2028 (US$ Million)
Figure 26. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 27. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Figure 28. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Figure 29. Latin America Tuberculosis (TB) Diagnostics Revenue Growth Rate 2017-2028 (US$ Million)
Figure 30. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2022)
Figure 31. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Figure 32. Latin America Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Figure 33. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 35. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Figure 36. Middle East and Africa Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Figure 37. Tuberculosis (TB) Diagnostics Supply Chain (Upstream and Downstream Market)
Figure 38. Global Production Market Share of Tuberculosis (TB) Diagnostics Raw Materials by Region in 2021
Figure 39. Tuberculosis (TB) Diagnostics Distribution Channels
Figure 40. Global Tuberculosis (TB) Diagnostics Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 41. Global Tuberculosis (TB) Diagnostics Percentage 2017-2028: Online Sales VS Offline Sales
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs